In contrast, the overexpression of USP30 partially reduced the benefits in AD symptoms brought about by miRNA-137-5p, indicating that downregulating USP30 is a vital mechanism through which miRNA-137-5p exerts its effects. This evidence concerns the gene USP30 and Alzheimer disease.